February 20, 2025, Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery ...
AZoLifeSciences on MSN14h
Harbour BioMed and Insilico Collaborate on Advanced AI-Driven Antibody DiscoveryHarbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and ...
Multi-laser picodroplets can be used in single cell analysis, sorting and dispensing - discover how in this article.
In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their ...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...
From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...
Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...
GlobalData on MSN9d
AbbVie and Xilio to collaborate on antibody-based immunotherapiesAbbVie has entered a partnership and option-to-license agreement with Xilio Therapeutics to develop new tumour-activated, ...
Alloy Therapeutics Inc. (“Alloy”), a biotechnology ecosystem company dedicated to democratizing access to cutting edge drug ...
At the recent annual congress of the European Association for Haemophilia and Allied Disorders, researchers from Novalgen Ltd. presented the discovery and preclinical characterization NVG-444, a ...
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback